Mouse models of diabetic nephropathy

Frank C. Brosius, Charles E. Alpers, Erwin P. Bottinger, Matthew D. Breyer, Thomas M. Coffman, Susan B. Gurley, Raymond C. Harris, Masao Kakoki, Matthias Kretzler, Edward H. Leiter, Moshe Levi, Richard A. McIndoe, Kumar Sharma, Oliver Smithies, Katalin Susztak, Nobuyuki Takahashi, Takamune Takahashi

Research output: Contribution to journalReview articlepeer-review

459 Scopus citations

Abstract

Diabetic nephropathy is a major cause of ESRD worldwide. Despite its prevalence, a lack of reliable animal models that mimic human disease has delayed the identification of specific factors that cause or predict diabetic nephropathy. The Animal Models of Diabetic Complications Consortium (AMDCC) was created in 2001 by the National Institutes of Health to develop and characterize models of diabetic nephropathy and other complications. This interim report and our online supplement detail the progress made toward that goal, specifically in the development and testing of murine models. Updates are provided on validation criteria for early and advanced diabetic nephropathy, phenotyping methods, the effect of background strain on nephropathy, current best models of diabetic nephropathy, negative models, and views of future directions. AMDCC investigators and other investigators in the field have yet to validate a complete murine model of human diabetic kidney disease. Nonetheless, the critical analysis of existing murine models substantially enhances our understanding of this disease process.

Original languageEnglish (US)
Pages (from-to)2503-2512
Number of pages10
JournalJournal of the American Society of Nephrology
Volume20
Issue number12
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Mouse models of diabetic nephropathy'. Together they form a unique fingerprint.

Cite this